Biologic Specimen and Data Repository Information Coordinating Center
Home > Proprietary Studies > BMT CTN 0102

Resources Available

Specimens Only

Materials Available

Peripheral Blood Mononuclear Cells (PBMC)
Stem Cell Product

Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)

Parent Study Contact: Alan Howard,
Study Type: Clinical Trial
Prepared on August 25, 2010
Consent: Proprietary Consent
Commercial Use Restrictions: No
Collection Type: Proprietary Study - See bottom of this webpage for request information


This study is a Phase III, multi-center trial of tandem autologous transplants versus the strategy of autologous followed by HLA-matched sibling non-myeloablative allogeneic transplant. Study subjects were assigned to the appropriate arm depending on the availability of an HLA-matched sibling. There is a nested randomized phase III trial of observation versus maintenance therapy following the second autologous transplant for patients on the tandem autologous transplant arm.